SCHEMBL4019339

SCHEMBL4019339

O=C(Cl)CCCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28024649 0.97
SCHEMBL1502438 0.91
SCHEMBL132364 0.84 TSHR (0.67)
SCHEMBL2154814 0.81 TSHR (0.72)
SCHEMBL7329781 0.81 TSHR (0.72)
SCHEMBL494288 0.81 TSHR (0.72)
Hydrochloric Acid SCHEMBL7947881 0.81 TSHR (0.63)
SCHEMBL495310 0.81 TSHR (0.72)
SCHEMBL2154041 0.81 TSHR (0.72)
SCHEMBL466419 0.81 TSHR (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103159670-A Synthetic method of apixaban intermediate 1-(4-nitrobenzophenone)-2-piperidone LANZHOU CHEM PHYS INST 2013-06-19 CN claimed
US-20090264648-A1 SYNTHESIS OF PYRAZOLES WYETH (US) 2009-10-22 US claimed
WO-2009091832-A1 SYNTHESIS OF PYRAZOLES WYETH (US) 2009-07-23 WO claimed
EP-3212620-B1 PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF JUBILANT GENERICS LTD FORMERLY JUBILANT LIFE SCIENCES DIVISION (IN) 2020-11-25 EP disclosed
EP-3212620-B1 PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF JUBILANT GENERICS LTD FORMERLY JUBILANT LIFE SCIENCES DIVISION (IN) 2020-11-25 EP disclosed
US-9932336-B2 Process for the preparation of apixaban and intermediates thereof Jubilant Generics Limited (IN) 2018-04-03 US disclosed
US-20170313699-A1 PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF Jubilant Generics Limited (IN) 2017-11-02 US disclosed
EP-3212620-A1 PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF Jubilant Generics Limited (Formerly Jubilant Life Sciences Division) (IN) 2017-09-06 EP disclosed
WO-2016067308-A1 PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF JUBILANT GENERICS LIMITED (FORMERLY JUBILANT LIFE SCIENCES DIVISION) (IN) 2016-05-06 WO disclosed
CN-104892601-A Preparation method of antithrombotic drug Apixaban JIANGSU ZHONGBANG PHARMACEUTICAL CO LTD 2015-09-09 CN disclosed
CN-104262338-A Synthetic method of apixaban and intermediate thereof ZHEJIANG TIANYU PHARMACY CO LTD 2015-01-07 CN disclosed
EP-0669329-B1 Difluorprostacyclins, intermediates for production thereof and processes for production thereof ASAHI GLASS CO LTD (JP) 1998-05-20 EP disclosed
US-5747531-A STABILITY; ANTICOAGULANTS, VASODILATORS ASAHI GLASS COMPANY LTD. (JP) 1998-05-05 US disclosed
EP-0789022-A1 Difluoroprostacyclins, intermediates for production thereof and process for production ASAHI GLASS COMPANY LTD. (JP) 1997-08-13 EP disclosed
US-5616732-A Intermediates for difluoroprostacyclins and methods for their production ASAHI GLASS COMPANY LTD. (JP) 1997-04-01 US disclosed
EP-0734386-A1 PLATELET ACTIVATING FACTOR ANTAGONISTS: IMIDAZOPYRIDINE INDOLES Abbott Laboratories (US) 1996-10-02 EP disclosed
US-5538995-A Difluoroprostacyclins ASAHI GLASS COMPANY LTD. (JP) 1996-07-23 US disclosed
US-5486525-A ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES (US) 1996-01-23 US disclosed
EP-0669329-A1 Difluorprostacyclins, intermediates for production thereof and processes for production thereof ASAHI GLASS COMPANY LTD. (JP) 1995-08-30 EP disclosed
WO-1995016687-A1 PLATELET ACTIVATING FACTOR ANTAGONISTS: IMIDAZOPYRIDINE INDOLES ABBOTT LABORATORIES (US) 1995-06-22 WO disclosed